Skip to main content
Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China flag China · Delayed Price · Currency is CNY
34.10
+1.50 (4.60%)
Apr 29, 2026, 3:04 PM CST

SHE:002422 Revenue

In the year 2025, Sichuan Kelun Pharmaceutical had annual revenue of 18.51B CNY, down -15.13%. Sichuan Kelun Pharmaceutical had revenue of 5.24B in the quarter ending December 31, 2025, with 4.23% growth.

Revenue
18.51B
Revenue Growth
-15.13%
P/S Ratio
2.82
Revenue / Employee
913.31K
Employees
20,127
Market Cap
51.85B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202518.51B-3.30B-15.13%
Dec 31, 202421.81B358.49M1.67%
Dec 31, 202321.45B2.42B12.69%
Jan 1, 202319.04B1.76B10.19%
Jan 1, 202217.28B813.21M4.94%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zhangzhou Pientzehuang Pharmaceutical., 9.78B
Zhejiang Wolwo Bio-Pharmaceutical 1.09B
Aurora Optoelectronics 465.12M
CSPC Hunan Jingfeng Pharmaceutical 393.19M
Yifan Pharmaceutical 5.06B
Zhejiang Jolly Pharmaceutical Co.,LTD 3.04B
Shanghai InnoStar Bio-tech 811.33M
GuangYuYuan Chinese Herbal Medicine 1.44B
Revenue Rankings

Sichuan Kelun Pharmaceutical News

More News